Elissa J. Schwartz - Net Worth and Insider Trading
Elissa J. Schwartz Net Worth
The estimated net worth of Elissa J. Schwartz is at least $2,950 dollars as of 2024-11-13. Elissa J. Schwartz is the Director of Galectin Therapeutics Inc and owns about 1,000 shares of Galectin Therapeutics Inc (GALT) stock worth over $2,950. Details can be seen in Elissa J. Schwartz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elissa J. Schwartz has not made any transactions after 2022-01-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elissa J. Schwartz
Elissa J. Schwartz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elissa J. Schwartz owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Elissa J. Schwartz’s form 4 insider trades.
Insider Ownership Summary of Elissa J. Schwartz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2022-01-21 | director |
Elissa J. Schwartz Latest Holdings Summary
Elissa J. Schwartz currently owns a total of 1 stock. Elissa J. Schwartz owns 1,000 shares of Galectin Therapeutics Inc (GALT) as of January 21, 2022, with a value of $2,950.
Latest Holdings of Elissa J. Schwartz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2022-01-21 | 1,000 | 2.95 | 2,950 |
Holding Weightings of Elissa J. Schwartz
Elissa J. Schwartz Form 4 Trading Tracker
According to the SEC Form 4 filings, Elissa J. Schwartz has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 1,000 shares on January 21, 2022, which cost Elissa J. Schwartz around $2,000.
Insider Trading History of Elissa J. Schwartz
- 1
Elissa J. Schwartz Trading Performance
GuruFocus tracks the stock performance after each of Elissa J. Schwartz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elissa J. Schwartz is -12.5%. GuruFocus also compares Elissa J. Schwartz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elissa J. Schwartz within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Elissa J. Schwartz's insider trading performs compared to the benchmark.
Performance of Elissa J. Schwartz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.17 | | | | | |
| Relative Return to S&P 500(%) | 5.29 | | | | | |
Elissa J. Schwartz Ownership Network
Ownership Network List of Elissa J. Schwartz
Ownership Network Relation of Elissa J. Schwartz
Elissa J. Schwartz Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Elissa J. Schwartz is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Elissa J. Schwartz made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net purchase of 16,300 shares made by Kevin D Freeman , and a net purchase of 4,500 shares made by Zordani Richard A. Jr. .
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 15,300 shares, with a net purchase of 15,300 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 25,198 shares were bought by its insiders, resulting in a net purchase of 198 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Elissa J. Schwartz Mailing Address
Above is the net worth, insider trading, and ownership report for Elissa J. Schwartz. You might contact Elissa J. Schwartz via mailing address: 235 Sw Church St., Pullman Wa 99163.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
